Evommune, Inc.
EVMN
$24.09
-$0.94-3.76%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 107.11% | -- | -- | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 119.61% | -- | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 107.44% | -- | -- | -- | |
|
|
|||||
| Total Current Assets | 107.44% | -- | -- | -- | |
| Net Property, Plant & Equipment | 36.99% | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 463.57% | -- | -- | -- | |
| Total Assets | 195.77% | -- | -- | -- | |
|
|
|||||
| Total Accounts Payable | -6.15% | -- | -- | -- | |
| Total Accrued Expenses | 41.88% | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 20.94% | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | -99.86% | -- | -- | -- | |
| Total Other Current Liabilities | -99.86% | -- | -- | -- | |
| Total Current Liabilities | -36.00% | -- | -- | -- | |
|
|
|||||
| Total Current Liabilities | -36.00% | -- | -- | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -32.04% | -- | -- | -- | |
|
|
|||||
| Common Stock & APIC | 5,245.21% | -- | -- | -- | |
| Retained Earnings | -45.24% | -- | -- | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 242.52% | -- | -- | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 242.52% | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 332.42% | -- | -- | -- | |
|
|
|||||